Quest diagnostics reports first quarter 2024 financial results; raises guidance for full year 2024

First quarter revenues of $2.37 billion, up 1.5% from 2023 first quarter reported diluted earnings per share ("eps") of $1.72, down 3.4% from 2023; and adjusted diluted eps of $2.04, flat with 2023 full year 2024 revenues now expected to be between $9.40 billion and $9.48 billion; reported diluted eps now expected to be between $7.57 and $7.82; and adjusted diluted eps expected to be between $8.72 and $8.97 secaucus, n.j. , april 23, 2024 /prnewswire/ -- quest diagnostics incorporated (nyse: dgx), a leading provider of diagnostic information services, today announced financial results for the first quarter ended march 31, 2024.
DGX Ratings Summary
DGX Quant Ranking